| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 01/08/2008 | US7317028 Antitumor agents; autoimmune disease; skin disorders; anticancer agents |
| 01/08/2008 | US7317013 such as N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-{4-[1-(2-hydroxyethyl)piperidin-4-yl]butyl} guanidine dihydrochloride and optionally with g-coupled receptor agonist or bronchodilators, used for promoting hydration of mucosal surfaces; improved pharmacokinetics |
| 01/08/2008 | CA2394027C New derivatives of octahydro-2h-pyrido[1,2-a] pyrazine, their preparation process and pharmaceutical compositions that contain them |
| 01/03/2008 | WO2008002820A2 Substituted benzyl amine compounds |
| 01/03/2008 | WO2008002817A1 Butyl and butynyl benzyl amine compounds |
| 01/03/2008 | WO2008002583A1 Glycine transporter-1 inhibitors |
| 01/03/2008 | WO2007117961A3 Renin inhibitors |
| 01/03/2008 | US20080004331 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition |
| 01/03/2008 | US20080004290 Anti-Cancer Agents |
| 01/03/2008 | US20080004289 Glycine transporter-1 inhibitors |
| 01/03/2008 | US20080004265 HIV Integrase Inhibitors |
| 01/03/2008 | US20080004262 2,2,7,9-tetramethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-pyrano[2,3-g]quinolin-3-ol; 3-hydroxy-2,2,9-trimethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-pyrano[2,3-g]quinolin-7-carbonitrile; have the prolongation effect on refractory period |
| 01/03/2008 | US20080004248 prostate cancer, benign prostatic hyperplasia, acne, seborrhea, hirsutism, androgenic alopecia, precocious puberty, adrenal hyperlasia and polycystic ovarian syndrome, breast cancer, endometriosis, leiomyoma and precocious puberty, estrogen dependent diseases |
| 01/03/2008 | CA2656089A1 Substituted benzyl amine compounds |
| 01/03/2008 | CA2656075A1 Butyl and butynyl benzyl amine compounds |
| 01/03/2008 | CA2655159A1 Glycine transporter-1 inhibitors |
| 01/02/2008 | EP1871749A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands |
| 01/02/2008 | EP1871739A1 Compounds which inhibit beta-secretase activity and methods of use thereof |
| 01/02/2008 | EP1871374A2 2,3 substituted pyrazine sulfonamides as inhibitors of crth2 |
| 01/02/2008 | EP1656361B1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
| 01/02/2008 | CN101096593A Organometallic compounds and emission-shifting organic electrophosphorescence |
| 01/02/2008 | CN101096592A Organometallic compounds and emission-shifting organic electrophosphorescence |
| 01/01/2008 | USRE39991 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 01/01/2008 | US7314937 Non-imidazole aryl alkylamines compounds as histamine H3 receptor antagonists, preparation and therapeutic uses |
| 01/01/2008 | US7314888 2-{5-[(2,4-diisobutoxyphenyl)(hydroxy)methyl]-2-isobutoxyphenyl}-acetic acid; inhibits the activity of transcription factor AP-1 |
| 12/27/2007 | WO2007149479A1 Pyrazine derivatives and uses thereof in renal monitoring |
| 12/27/2007 | WO2007149478A2 Pyrazine derivatives with extended conjugation and uses thereof |
| 12/27/2007 | WO2007149448A2 Pyrazinones as cellular proliferation inhibitors |
| 12/27/2007 | WO2007148774A1 Cyclic amine compound |
| 12/27/2007 | WO2007148711A1 N-(3,4-disubstituted phenyl)salicylamide derivative |
| 12/27/2007 | WO2007147746A1 2-pyrazinecarboxamide derivatives |
| 12/27/2007 | WO2007147217A1 Method of treatment of glioma brain tumour |
| 12/27/2007 | WO2004058735A3 Ligands of melanocortin receptors and compositions and methods related thereto |
| 12/27/2007 | US20070299263 Hydroxy Alkyl Amines |
| 12/27/2007 | US20070299080 Benzamide derivatives and uses related thereto |
| 12/27/2007 | US20070299077 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 12/27/2007 | US20070299072 Kv1.5 potassium channel inhibitors |
| 12/27/2007 | US20070299064 Pesticidal Heterocyclic Dihaloallyl Compounds |
| 12/27/2007 | CA2656825A1 Method of treatment and agents useful for same |
| 12/27/2007 | CA2655857A1 Pyrazine derivatives with extended conjugation and uses thereof |
| 12/27/2007 | CA2654781A1 2-pyrazinecarboxamide derivatives |
| 12/27/2007 | CA2652859A1 Pyrazinones as cellular proliferation inhibitors |
| 12/27/2007 | CA2628661A1 Pyrazine derivatives and uses thereof in renal monitoring |
| 12/26/2007 | EP1870396A1 Benzyloxypropylamine derivative |
| 12/26/2007 | EP1869059A1 Organometallic complex, and light-emitting element, light-emitting device and electronic device using the organometallic complex |
| 12/26/2007 | EP1868986A1 Tetrahydronaphthalene derivatives method for the production and the use thereof in the form of antiphlogistics |
| 12/26/2007 | EP1868605A2 Phenyl and pyridyl lta4h modulators |
| 12/26/2007 | CN101094841A Indinavir derivatives useful in immunoassay |
| 12/26/2007 | CN101092402A New compound in sulfonyl ureas, and medicine use |
| 12/26/2007 | CN101092401A Stereoselective alkylation of chiral 2-methyl-4-protected piperazines |
| 12/26/2007 | CN100357276C Quinoline and quinoxaline compounds as PDGF-R and/or LCD tyrosine kinase inhibitors |
| 12/26/2007 | CN100357275C N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 12/25/2007 | US7312333 N-heterocyclic hydroxyethylamine compounds; human immunodeficiency virus (HIV) protease |
| 12/25/2007 | US7312246 Inhibiting interaction of alpha-helical protein with another protein or binding site; inhibiting cellular invasion of HIV |
| 12/25/2007 | US7312218 For use as anticoagulant agents for therapy of thromboembolic disorders; 6-chloro-naphthalene-2-sulfonic acid [1-(1-cyclopentyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide; )-2-methyl-benzothiazole-6-sulfonic acid [1-(1-isopropyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide |
| 12/21/2007 | WO2007146870A1 Cyclic substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity |
| 12/21/2007 | WO2007146553A2 N-[2-[[(diaminomethylene)amino]oxy]ethyl]-3-[(2,2-difluoro-2-phenylethyl)amino]-6-methyl-2-oxo-1(2h)-pyrazineacetamide |
| 12/21/2007 | WO2007146066A2 Novel piperazines, pharmaceutical compositions and methods of use thereof |
| 12/21/2007 | WO2007144579A1 N-oxides of diarylurea derivatives and their use as chk1 inhibitors for the treatment of cancer |
| 12/21/2007 | WO2007144409A1 Stereoselective synthesis of (s)-1-methyl-3-phenylpiperazine |
| 12/21/2007 | CA2659512A1 Novel piperazines, pharmaceutical compositions and methods of use thereof |
| 12/21/2007 | CA2653773A1 Cyclic substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity |
| 12/21/2007 | CA2653039A1 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics |
| 12/20/2007 | US20070293673 N-phenyl-2-pyrimidine-amine derivatives |
| 12/20/2007 | US20070293672 N-phenyl-2-pyrimidine-amine derivatives |
| 12/20/2007 | US20070293540 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition |
| 12/20/2007 | US20070293509 treating eating disorders, obesity, type II diabetes, and substance abuse and/or addiction (including alcohol dependency and nicotine dependency); 6-(4-chloro-phenyl)-5-[methyl-(3-methyl-butyl)-amino]-pyrazine-2-carboxylic acid ((R)-2-cyclopropyl-2-hydroxy-propyl)-amide |
| 12/20/2007 | US20070293504 N-phenyl-2-pyrimidine-amine derivatives |
| 12/20/2007 | US20070293495 to treat Alzheimer's disease,Down syndrome and the other diseases associated with amyloid deposition; thiomethane, sulfinylmethane or sulfonylmethane compounds; 5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]-2-(4'-hydroxypiperidin-1'-yl)pyridine |
| 12/20/2007 | US20070293491 Indazole compounds and methods for inhibition of cdc7 |
| 12/20/2007 | US20070292933 Inhibitors of serine proteases, particular HCV NS3-NS4A protease |
| 12/19/2007 | EP1866321A1 Organometallic complex, and light-emitting device and electronic appliance using the same |
| 12/19/2007 | EP1664031B1 Adamantane and azabicyclo-octane and nonane derivatives process of their preparation and their use as dpp-iv inhibitors |
| 12/19/2007 | EP1490062B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/19/2007 | EP1032556B1 Pharmaceutically active compounds and methods of use |
| 12/19/2007 | CN101090883A Substituted hydroxyethylamines |
| 12/19/2007 | CN100355728C Inhibitors of dipeptidyl peptidase IV |
| 12/18/2007 | US7309702 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; Alzheimer's disease |
| 12/13/2007 | US20070287697 Cgrp Receptor Antagonists |
| 12/13/2007 | US20070286842 serine protease inhibitors, for the treatment of hepatitis c virus infections |
| 12/12/2007 | EP1863774A2 Heterocyclical chromophore architectures with novel electronic acceptor systems |
| 12/12/2007 | EP1863766A2 Certain substituted amides, method of making, and method of use thereof |
| 12/12/2007 | EP1492794B1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders |
| 12/12/2007 | CN101087767A Fluorescent pyrazine derivatives and methods of using the same in assessing renal function |
| 12/12/2007 | CN101087755A Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 12/12/2007 | CN101085760A Ligustrazine stilbenoids derivatives, preparation method thereof, medicament composition and use |
| 12/12/2007 | CN100354271C Piperazine derivatives and process for the preparation thereof |
| 12/12/2007 | CN100354267C Preventives or remedies for alzheimer's disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds |
| 12/11/2007 | US7307169 Isotopically enriched N-substituted piperazines and methods for the preparation thereof |
| 12/11/2007 | US7307087 Antidepressants; analgesics; antiinflammatory agents; side effect reduction |
| 12/11/2007 | CA2393271C Retroviral protease inhibiting compounds |
| 12/06/2007 | WO2007139081A1 Anti-foot-and-mouth disease virus agent for animal belonging to family suidae or sheep, and method for prevention or treatment of foot-and-mouth disease in animal belonging to family suidae or sheep |
| 12/06/2007 | WO2007139002A1 Method for producing nitrogen-containing fused ring compound |
| 12/06/2007 | WO2007138998A1 Pharmaceutical composition comprising nitrogenated fused cyclic compound |
| 12/06/2007 | WO2007138112A2 Compounds that interact with ion channels, in particular with ion channels from the kv family |
| 12/06/2007 | WO2007072143A3 Chemical compounds |
| 12/06/2007 | US20070282100 Boronic ester and acid compounds, synthesis and uses |
| 12/06/2007 | CA2653933A1 Anti-foot-and-mouth disease virus agent for animal belonging to family suidae or sheep, and method for prevention or treatment of foot-and-mouth disease in animal belonging to family suidae or sheep |
| 12/05/2007 | EP1862179A1 Novel use of sulfonamide compound in combination with angiogenesis inhibitor |
| 12/05/2007 | EP1499319B1 Bicyclo 4.4.0 antiviral derivatives |